openPR Logo

Press Releases from Healthcare Opportunity (1 total)

England’s NICE rejects Novartis’ migraine treatment drug Aimovig

The National Institute for Health and Care Excellence (NICE), the public body under the Department of Health in England, has reportedly rejected Novartis’ migraine treatment

Go To Page: